Announcements Trials
Browse Landscape

Phase

Phase 2 50Phase 1 41Phase 1/2 23Phase 3 5Phase NA 2Phase EARLY_PHASE1 2Phase 4 1Phase 2/3 1

Status

Completed 53Active not recruiting 38Recruiting 25Unknown 10Terminated 5Withdrawn 3Not yet recruiting 3

Sponsor Class

INDUSTRY 2OTHER 1NIH 1NETWORK 1

Study Type

Interventional 5

Sponsor

Cancer Type

Plasma cell 3Lymphoid 2Dermatologic 1

Conditions

Multiple Myeloma 3Sezary Syndrome 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma 1

Interventions

Cisplatin 62Carboplatin 52Paclitaxel 48Radiotherapy 47Docetaxel 41Gemcitabine 38Cyclophosphamide 36Rituximab 33Capecitabine 28Fluorouracil 27Dexamethasone 27Doxorubicin 26Prednisone 21Bevacizumab 20Pemetrexed 19Oxaliplatin 18Leucovorin 18pembrolizumab 17Vincristine 17Etoposide 17Cytarabine 15Drug Therapy 14Irinotecan 13Imatinib Mesylate 13Filgrastim 13Zoledronic Acid 12Radiosurgery 12Erlotinib Hydrochloride 12Trastuzumab 11Goserelin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × Terminated × Lenalidomide × Clear all
NCT02516696 2023-06-05

BiRd vs Rd

Weill Medical College of Cornell University

Phase 3 Terminated
12 enrolled 19 charts
Plasma cell

Multiple Myeloma

NCT02579863 2021-07-20

KEYNOTE 185

Merck Sharp & Dohme LLC

Phase 3 Terminated
310 enrolled 16 charts
Plasma cell

Multiple Myeloma

NCT01021423 2019-11-19

RENEW

Celgene

Phase 3 Terminated
9 enrolled 10 charts
Lymphoid

Lymphoma, Non-Hodgkin, Lymphoma, Mantle-Cell

NCT01098656 2018-07-09

Lenalidomide Maintenance Post-debulking in Advanced CTCL

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Terminated
21 enrolled
DermatologicLymphoid

Lymphoma, Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

NCT00522392 2015-06-26

Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone

National Cancer Institute (NCI)

Phase 3 Terminated
48 enrolled 9 charts
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡